An observational study of antipsychotic medication use among long-stay nursing home residents without qualifying diagnoses

Journal of Psychiatric and Mental Health Nursing

Volumn 25, Issue 8, 2018, Pages 463-474

  Phillips, Lorraine J ^a   Birtley, Nancy M ^b   Petroski, Gregory F ^c   Siem, Carol ^b   Rantz, Marilyn ^b  

^a UNIVERSITY OF DELAWARE   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c University of Missouri   (United States)

Author keywords

antipsychotic medication; minimum data set; nursing home

Indexed keywords

NEUROLEPTIC AGENT;

AGED; DEMENTIA; FEMALE; HUMAN; LONG TERM CARE; MALE; MEDICAID; MEDICARE; MISSOURI; NURSING HOME; PRESCRIPTION; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGED; ANTIPSYCHOTIC AGENTS; DEMENTIA; DRUG PRESCRIPTIONS; FEMALE; HUMANS; LONG-TERM CARE; MALE; MEDICAID; MEDICARE; MISSOURI; NURSING HOMES; UNITED STATES;

EID: 85052509988     PISSN: 13510126     EISSN: 13652850     Source Type: Journal    
DOI: 10.1111/jpm.12488     Document Type: Article

References (71)

1. Agüero-Torres, H., von Strauss, E., Viitanen, M., Winblad, B., & Fratiglioni, L. (2001). Institutionalization in the elderly: The role of chronic diseases and dementia. Cross-sectional and longitudinal data from a population-based study. Journal of Clinical Epidemiology, 54(8), 795–801. https://doi.org/10.1016/S0895-4356(00)00371-1
2. Alzheimer's Association. (2017). 2017 Alzheimer's disease facts and figures. Alzheimer's & Dementia, 13, 325–373.
3. American Health Care Association. (2014). American health care association 2012 staffing report. American Health Care Association Department of Research. Washington, DC. Author. Retrieved from http://www. ahcancal. org/research_data/staffing/Documents/2012_Staffing_Repor t. pdf.
4. Bakker, R. (2003). Sensory loss, dementia, and environments. Generations: Journal on the American Society on Aging, 27(1), 46–51.
5. Ballard, C. G., Waite, J., & Birks, J. (2012). Atypical antipsychotics for aggression and psychosis in Alzheimer's disease. Cochrane Database of Systematic Reviews, 5, 1–131. https://doi.org/10.1012/14651858.CD003476.pub2
6. Bergh, S., & Selbæk, G. (2012). The prevalence and the course of neuropsychiatric symptoms in patients with dementia. Norsk Epidemiologi, 22(2), 225–232.
7. Birtley, N. M. (2016). Psychotropic alternatives to antipsychotic medications in treating dementia behaviors. Journal of Psychosocial Nursing and Mental Health Services, 54(10), 45–53.
8. Brooker, D. J., Latham, I., Evans, S. C., Jacobson, N., Perry, W., Bray, J., … Pickett, J. (2016). FITS into practice: Translating research into practice in reducing the use of anti-psychotic medication for people with dementia living in care homes. Aging & Mental Health, 20(7), 709–718. https://doi.org/10.1080/13607863.2015.1063102
9. Centers for Medicare and Medicaid Services. (2001). Appropriateness of Minimum Nurse Staffing Ratios in Nursing Homes: Phase II Final Report. Washington, DC: US Government Printing Office.
10. Centers for Medicare & Medicaid Services. (2013). Advanced copy: Dementia care in nursing homes: Clarification to Appendix P State Operations Manual (SOM) and Appendix PP in the SOM for F309—Quality of Care and F329—Unnecessary drugs. Retrieved from https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Policy-and-Memos-to-States-and-Regions-Items/Survey-and-Cert-Letter-13-35.html
11. Centers for Medicare & Medicaid Services. (2017a). National partnership to improve dementia care in nursing homes: Antipsychotic medication use data report (October 2017). Retrieved from https://www.nhqualitycampaign.org/files/AP_package_20171016.pdf
12. Centers for Medicare & Medicaid Services. (2017b). Long-Term Care Facility Resident Assessment Instrument 3.0 User's Manual, Version 1.15. Retrieved from https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/NursingHomeQualityInits/MDS30RAIManual.html
13. Centers for Medicare & Medicaid Services. (2017c). Quality Measures. Retrieved from https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/NursingHomeQualityInits/NHQIQualityMeasures.html
14. Centers for Medicare & Medicaid Services. (2017d). State Operations Manual. Appendix PP - Guidance to Surveyors for Long Term Care Facilities. Revised 11/22/17. Retrieved from https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/GuidanceforLawsAndRegulations/Nursing-Homes.html
15. Chen, Y., Briesacher, B. A., Field, T. S., Tjia, J., Lau, D. T., & Gurwitz, J. H. (2010). Unexplained variation across US nursing homes in antipsychotic prescribing rates. Archives of Internal Medicine, 170(1), 89–95. https://doi.org/10.1001/archinternmed.2009.469
16. Cioltan, H., Alshehri, S., Howe, C., Lee, J., Fain, M., Eng, H., … Mohler, J. (2017). Variation in use of antipsychotic medications in nursing homes in the United States: A systematic review. BMC Geriatrics, 17(1), 32. https://doi.org/10.1186/s12877-017-0428-1
17. Cohen-Mansfield, J. (2001). Nonpharmacological interventions for inappropriate behaviors in dementia: A review, summary, and critique. American Journal of Geriatric Psychiatry, 9(4), 361–381. https://doi.org/10.1097/00019442-200111000-00005
18. Cohen-Mansfield, J., Werner, P., Marx, M. S., & Freedman, L. (1991). Two studies of pacing in the nursing home. Journal of Gerontology, 46(3), M77–M83. https://doi.org/10.1093/geronj/46.3.M77
19. Coon, J. T., Abbott, R., Rogers, M., Whear, R., Pearson, S., Lang, I., … Stein, K. (2014). Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: A systematic review. Journal of the American Medical Directors Association, 15(10), 706–718. https://doi.org/10.1016/j.jamda.2014.06.012
20. Declercq, T., Petrovic, M., Azermai, M., Vander Stichele, R., De Sutter, A. I., vanDriel, M. L., & Christiaens, T. (2013). Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database of Systematic Reviews, (4), CD007726-1.
21. Dewing, J. (2009). Caring for people with dementia: Noise and light. Nursing Older People, 21(5), 34–38. https://doi.org/10.7748/nop2009.06.21.5.34.c7102
22. Eaker, E. D., Vierkant, R. A., & Mickel, S. F. (2002). Predictors of nursing home admission and/or death in incident Alzheimer's disease and other dementia cases compared to controls: A population-based study. Journal of Clinical Epidemiology, 55(5), 462–468. https://doi.org/10.1016/S0895-4356(01)00498-X
23. Fan, J., Upadhye, S., & Worster, A. (2006). Understanding receiver operating characteristic (ROC) curves. Canadian Journal of Emergency Medicine, 8(1), 19–20.
24. Fitzsimmons, S., Barba, B., Stump, M., & Bonner, A. (2014). Nonpharmacological interventions in long term care: Feasibility and recent trends. Journal of Gerontological Nursing, 40(5), 10–14. https://doi.org/10.3928/00989134-20140324-04
25. Fossey, J., Ballard, C., Juszczak, E., James, I., Alder, N., Jacoby, R., & Howard, R. (2006). Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: Cluster randomised trial. BMJ, 332(7544), 756–761. https://doi.org/10.1136/bmj.38782.575868.7C
26. Gellad, W. F., Aspinall, S. L., Handler, S. M., Stone, R. A., Castle, N., Semla, T. P., … Hanlon, J. T. (2012). Use of antipsychotics among older residents in Veterans Administration nursing homes. Medical Care, 50(11), 954. https://doi.org/10.1097/MLR.0b013e31825fb21d
27. Gill, S. S., Rochon, P. A., Herrmann, N., Lee, P. E., Sykora, K., Gunraj, N., & Mamdani, M. (2005). Atypical antipsychotic drugs and risk of ischaemic stroke: Population based retrospective cohort study. British Medical Journal, 330(7489), 445. https://doi.org/10.1136/bmj.38330.470486.8F
28. Gordon, S. E., Dufour, A. B., Monti, S. M., Mattison, M. L., Catic, A. G., Thomas, C. P., & Lipsitz, L. A. (2016). Impact of a videoconference educational intervention on physical restraint and antipsychotic use in nursing homes: Results from the ECHO-AGE pilot study. Journal of the American Medical Directors Association, 17(6), 553–556. https://doi.org/10.1016/j.jamda.2016.03.002
29. Gurwitz, J. H., Bonner, A., & Berwick, D. M. (2017). Reducing excessive use of antipsychotic agents in nursing homes. JAMA, 318(2), 118–119. https://doi.org/10.1001/jama.2017.7032
30. Harrington, C., Carrillo, H., Blank, B. W., & O'Brian, T. (2010). Nursing Facilities, Staffing, Residents, and Facility Deficiencies, 2004 through 2009. San Francisco, CA: University of California.
31. Harrington, C., Carrillo, H., & Garfield, R. (2017). Nursing Facilities, Staffing, Residents and Facility Deficiencies, 2009 through 2015. Menlo Park, CA: The Henry J. Kaiser Family Foundation.
32. Harrington, C., Schnelle, J. F., McGregor, M., & Simmons, S. F. (2016). The need for higher minimum staffing standards in US nursing homes. Health Services Insights, 9, 13–19.
33. Harris-Kojetin, L., Sengupta, M., Park-Lee, E., Valverde, R., Caffrey, C., Rome, V., & Lendon, J. (2016). Long-term care providers and services users in the United States: Data from the National Study of Long-Term Care Providers, 2013-2014. Vital & Health Statistics. Series 3, Analytical and epidemiological studies/[US Dept. of Health and Human Services, Public Health Service, National Center for Health Statistics], 38, 1–118.
34. Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A. (2013). Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology, 80(19), 1778–1783. https://doi.org/10.1212/WNL.0b013e31828726f5
35. Hendrix, C. C., Sakauye, K. M., Karabatsos, G., & Daigle, D. (2003). The use of the Minimum Data Set to identify depression in the elderly. Journal of the American Medical Directors Association, 4, 308–312. https://doi.org/10.1016/S1525-8610(04)70389-8
36. Hosmer, D. W., & Lemeshow, S. (1989). Applied Logistic Regression. New York, NY: Wiley & Sons.
37. Hughes, C. M., Lapane, K. L., & Mor, V. (2000). Influence of facility characteristics on use of antipsychotic medications in nursing homes. Medical Care, 38(12), 1164–1173. https://doi.org/10.1097/00005650-200012000-00003
38. Kamble, P., Chen, H., Sherer, J. T., & Aparasu, R. R. (2009). Use of antipsychotics among elderly nursing home residents with dementia in the US. Drugs and Aging, 26(6), 483–492. https://doi.org/10.2165/00002512-200926060-00005
39. Kash, B. A., Hawes, C., & Phillips, C. D. (2007). Comparing staffing levels in the Online Survey Certification and Reporting (OSCAR) system with the Medicaid Cost Report data: Are differences systematic? The Gerontologist, 47(4), 480–489. https://doi.org/10.1093/geront/47.4.480
40. Lai, C. K. Y., & Arthur, D. G. (2003). Wandering behavior in people with dementia. Journal of Advanced Nursing, 44(2), 173–182. https://doi.org/10.1046/j.1365-2648.2003.02781.x
41. Levin, C. A., Wei, W., Akincigil, A., Lucas, J. A., Bilder, S., & Crystal, S. (2007). Prevalence and treatment of diagnosed depression among elderly nursing home residents in Ohio. Journal of the American Medical Directors Association, 8(9), 585–594. https://doi.org/10.1016/j.jamda.2007.07.010
42. Lin, H. (2014). Revisiting the relationship between nurse staffing and quality of care in nursing homes: An instrumental variables approach. Journal of Health Economics, 37, 13–24. https://doi.org/10.1016/j.jhealeco.2014.04.007
43. Livingston, G., Johnston, K., Katona, C., Paton, J., & Lyketsos, C. (2005). Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. American Journal of Psychiatry, 162(11), 1996–2021. https://doi.org/10.1176/appi.ajp.162.11.1996
44. Lucas, J. A., & Bowblis, J. R. (2017). CMS strategies to reduce antipsychotic drug use in nursing home patients with dementia show some progress. Health Affairs, 36(7), 1299–1308. https://doi.org/10.1377/hlthaff.2016.1439
45. Lucas, J. A., Chakravarty, S., Bowblis, J. R., Gerhard, T., Kalay, E., Paek, E. K., & Crystal, S. (2014). Antipsychotic medication use in nursing homes: A proposed measure of quality. International Journal of Geriatric Psychiatry, 29(10), 1049–1061. https://doi.org/10.1002/gps.4098
46. Lucero, M. (2002). Intervention strategies for exit-seeking wandering behavior in dementia residents. American Journal of Alzheimer's Disease and Other Dementias, 17(5), 277–280. https://doi.org/10.1177/153331750201700509
47. Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J., & DeKosky, K. (2002). Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the Cardiovascular Health Study. Journal of the American Medical Association, 288(12), 1475–1483. https://doi.org/10.1001/jama.288.12.1475
48. Maglione, M., Maher, A. R., Hu, J., Wang, Z., Shanman, R., Shekelle, P. G., & Motala, A. (2011). Off-Label Use of Atypical Antipsychotics: An Update. Comparative Effectiveness Reviews, No. 43. Rockville, MD: Agency for Healthcare Research and Quality (US).
49. Mendez, M. F., Fras, I. A., Kremen, S. A., & Tsai, P. (2011). False reports from patients with frontotemporal dementia: Delusions or confabulations? Behavioral Neurology, 24, 237–244. https://doi.org/10.3233/BEN-2011-0335
50. Morris, J. N., Fries, B. E., Mehr, D. R., Hawes, C., Phillips, C., Mor, V., & Lipsitz, L. A. (1994). MDS cognitive performance scale©. Journal of Gerontology, 49(4), M174–M182. https://doi.org/10.1093/geronj/49.4.M174
51. National Guideline Clearinghouse. (2008). Delirium and acute problematic behavior in the long-term care setting. Retrieved from https://www.guideline.gov/summaries/summary/12379/delirium-and-acute-problematic-behavior-in-the-longterm-care-setting?q=delirium+treatment
52. National Guideline Clearinghouse. (2013a). Guideline summary: Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Retrieved from https://www.guideline.gov/summaries/summary/43903/clinical-practice-guidelines-for-the-management-of-pain-agitation-and-delirium-in-adult-patients-in-the-intensive-care-unit?q=pain+agitation+and+delirium
53. National Guideline Clearinghouse. (2013b). Guideline summary: Australian guidelines for the treatment of acute stress disorder & posttraumatic stress disorder. Retrieved from https://www.guideline.gov/summaries/summary/49219/australian-guidelines-for-the-treatment-of-acute-stress-disorder-posttraumatic-stress-disorder?dPTSD
54. National Institute for Health and Care Excellence. (2005). Post-traumatic stress disorder: Management. Retrieved from https://www.nice.org.uk/guidance/cg26
55. Nelson, J. C., Delucchi, K., & Schneider, L. S. (2008). Efficacy of second generation antidepressants in late-life depression: A meta-analysis of the evidence. The American Journal of Geriatric Psychiatry, 16(7), 558–567. https://doi.org/10.1097/01.JGP.0000308883.64832.ed
56. Patterson, S. M., Hughes, C. M., Crealey, G., Cardwell, C., & Lapane, K. L. (2010). An evaluation of an adapted US model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland study). Journal of the American Geriatrics Society, 58(1), 44–53. https://doi.org/10.1111/j.1532-5415.2009.02617.x
57. Petek Šter, M., & Cedilnik Gorup, E. (2011). Psychotropic medication use among elderly nursing home residents in Slovenia: Crosssectional study. Croatian Medical Journal, 52(1), 16–24. https://doi.org/10.3325/cmj.2011.52.16
58. Ravona-Springer, R., & Davidson, M. (2014). Considerations in psychotropic treatments in dementia—can polypharmacy be avoided? International Journal of Neuropsychopharmacology, 17, 1107–1117. https://doi.org/10.1017/S1461145713000412
59. Richter, T., Meyer, G., Mohler, R., & Kopke, R. (2012). Psychosocial interventions for reducing antipsychotic medication in care home residents (Review). The Cochrane Database of Systematic Reviews, 12, 1–45. https://doi.org/10.1002/14651858.CD008634.pub2
60. Saliba, D., & Buchanan, J. (2008). Development & validation of a revised nursing home assessment tool: MDS 3.0. Rand Health Corporation. Retrieved from https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/NursingHomeQualityInits/downloads/MDS30FinalReport.pdf
61. Sawyer, P., Lillis, J. P., Bodner, E. V., & Allman, R. M. (2007). Substantial daily pain among nursing home residents. Journal of the American Medical Directors Association, 8(3), 158–165. https://doi.org/10.1016/j.jamda.2006.12.030
62. Schneider, L. S., Dagerman, K. S., & Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. Journal of the American Medical Association, 294(15), 1934–1943. https://doi.org/10.1001/jama.294.15.1934
63. Seignourel, P. J., Kunik, M. E., Snow, L., Wilson, N., & Stanley, M. (2008). Anxiety in dementia: A critical review. Clinical Psychology Review, 28, 1071–1082. https://doi.org/10.1016/j.cpr.2008.02.008
64. Selbæk, G., Engedal, K., & Bergh, S. (2013). The prevalence and course of neuropsychiatric symptoms in nursing home patients with dementia: A systematic review. Journal of the American Medical Directors Association, 14(3), 161–169. https://doi.org/10.1016/j.jamda.2012.09.027
65. Svarstad, B. L., Mount, J. K., & Bigelow, W. (2001). Variations in the Treatment Culture of Nursing Homes and Responses to Regulations to Reduce Drug Use. Psychiatric Services, 52(5), 666–672. https://doi.org/10.1176/appi.ps.52.5.666
66. Tawiah, P., Black, M., Scott-Walker, M., Johnson, E., & Vaughan, C. P. (2016). Reducing antipsychotic use through culture change: An interdisciplinary effort. Annals of Long-Term Care: Clinical Care and Aging, 24(10), 27–32.
67. U.S. Food and Drug Administration. (2008). Information for Healthcare Professionals: Conventional Antipsychotics. Retrieved from https://wayback.archive-it.org/7993/20170406044836/https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124830.htm
68. Wergeland, J. N., Selbæk, G., Bergh, S., Soederhamn, U., & Kirkevold, Ø. (2015). Predictors for nursing home admission and death among community-dwelling people 70 years and older who receive domiciliary care. Dementia and Geriatric Cognitive Disorders Extra, 5(3), 320–329. https://doi.org/10.1159/000437382
69. Wysocki, A., Thomas, K. S., & Mor, V. (2015). Functional improvement among short-stay nursing home residents in the MDS 3.0. Journal of the American Medical Directors Association, 16(6), 470–474. https://doi.org/10.1016/j.jamda.2014.11.018
70. Zuidema, S. U., Derksen, E., Verhey, F. R., & Koopmans, R. T. (2007). Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia. International Journal of Geriatric Psychiatry, 22(7), 632–638. https://doi.org/10.1002/(ISSN)1099-1166
71. Zuidema, S. U., Johansson, A., Selbaek, G., Murray, M., Burns, A., Ballard, C., & Koopmans, R. (2015). A consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientific evidence and clinical practice. International. Geriatrics, 27(11), 1849–1859. https://doi.org/10/1017/S10416102215000745